A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to see how well alendronate and calcium as compared to calcium alone increase bone density in postmenopausal women with osteoporosis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Alendronate; Calcium; Calcium Carbonate; Calcium, Dietary

Criteria

Inclusion Criteria :

• Patient is postmenopausal (or surgically menopausal) for at least 5 years.

• Patient must be diagnosed with osteoporosis

• Patient has spinal anatomy suitable for DEXA of the lumbar spine

Exclusion Criteria :

• Patient is receiving or has received treatment prior to randomization which might influence bone turnover

• Patient has a history of or evidence for metabolic bone disease (other than postmenopausal bone loss)

• Patient is receiving or is expected to receive during the course of the study any medication (other than study medication) which might alter bone or calcium metabolism